Project Details
Description
A randomized, open-label study to assess the safety and tolerability of AT2101 in treatement-native adult patients with type 1 Gaucher disease
| Status | Finished |
|---|---|
| Effective start/end date | 2/27/07 → 12/31/09 |
Funding
- AMICUS THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.